Vitestro
Private Company
Total funding raised: $17M
Overview
Vitestro is a pioneering medical device company based in Utrecht, Netherlands, focused on automating one of the most common yet variable procedures in healthcare: the blood draw. Its flagship product, Aletta®, is an autonomous robotic system that performs venipuncture from vein identification to bandage application, having achieved CE Marking under the European MDR. The company has secured significant funding, demonstrated clinical efficacy with a 95% first-stick success rate, and is moving into initial commercial deployments with hospital partners in Europe and a strategic collaboration in the US. Vitestro addresses critical challenges of staffing shortages, preanalytical errors, and procedural standardization in the global diagnostic workflow.
Technology Platform
Autonomous Robotic Phlebotomy Device (ARPD) combining 3D ultrasound imaging, AI-driven vein mapping, robotic needle insertion, and automated sample handling to perform complete blood draws.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Vitestro appears to be a first-mover in fully autonomous, end-to-end robotic phlebotomy. The competitive landscape includes companies offering vein-finding devices (e.g., infrared viewers) and semi-automated blood drawing aids, but not a fully integrated robotic system. Potential future competitors could include large laboratory automation firms or medical robotics companies expanding into adjacent applications.